troglitazone has been researched along with thromboxane a2 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hishinuma, T; Mizugaki, M; Yamazaki, T | 1 |
| Hishinuma, T; Mizugaki, M; Suzuki, H; Tomioka, Y; Yamazaki, T; Yokoo, T | 1 |
2 other study(ies) available for troglitazone and thromboxane a2
| Article | Year |
|---|---|
Troglitazone has a reducing effect on thromboxane production.
Topics: Arachidonic Acid; Blood Platelets; Chromans; Diabetes Mellitus, Type 2; Fibrinolytic Agents; Gas Chromatography-Mass Spectrometry; Humans; Leukemia, Erythroblastic, Acute; Rosiglitazone; Thiazoles; Thiazolidinediones; Thromboxane A2; Troglitazone; Tumor Cells, Cultured; Vitamin E | 2000 |
Effect of peroxisome proliferator-activated receptor gamma on thromboxane A(2) and prostaglandin E(2) production in macrophage cell lines.
Topics: Animals; Cell Line; Chromans; Dinoprostone; Humans; Ligands; Macrophages; Monocytes; Receptors, Cytoplasmic and Nuclear; Thiazoles; Thiazolidinediones; Thromboxane A2; Transcription Factors; Transfection; Troglitazone | 2002 |